Showing results (31-40 of 44) with videos related to
Sort By:
Pageof 5
Combinatorial Chemistry & High Throughput Screening|May 12, 2004
Making sense of molecular signatures in the immune systemNicholas J Davies, Mahlet G T Tadesse, Marina Vannucci, et al.Iscience|March 28, 2024
Heterogeneous subpopulations of GABAAR-responding neurons coexist across neuronal network scales and developmental stages in health and diseaseIlaria Colombi, Mohit Rastogi, Martina Parrini, et al.Journal of Medicinal Chemistry|June 17, 2021
Design, Synthesis, In Vitro and In Vivo Characterization of Selective NKCC1 Inhibitors for the Treatment of Core Symptoms in Down SyndromeMarco Borgogno, Annalisa Savardi, Jacopo Manigrasso, et al.Neuron|October 7, 2020
Rescuing Over-activated Microglia Restores Cognitive Performance in Juvenile Animals of the Dp(16) Mouse Model of Down SyndromeBruno Pinto, Giovanni Morelli, Mohit Rastogi, et al.Biometrics|September 2, 2004
Bayesian variable selection in multinomial probit models to identify molecular signatures of disease stageNaijun Sha, Marina Vannucci, Mahlet G Tadesse, et al.Chem|August 21, 2020
Discovery of a Small Molecule Drug Candidate for Selective NKCC1 Inhibition in Brain DisordersAnnalisa Savardi, Marco Borgogno, Roberto Narducci, et al.Molecular Therapy : the Journal of the American Society of Gene Therapy|May 31, 2021
Restoring neuronal chloride homeostasis with anti-NKCC1 gene therapy rescues cognitive deficits in a mouse model of Down syndromeMartina Parrini, Shovan Naskar, Micol Alberti, et al.The EMBO Journal|October 24, 2013
REST/NRSF-mediated intrinsic homeostasis protects neuronal networks from hyperexcitabilityDavide Pozzi, Gabriele Lignani, Enrico Ferrea, et al.Molecular Therapy : the Journal of the American Society of Gene Therapy|September 10, 2019
SINEUP Non-coding RNA Targeting GDNF Rescues Motor Deficits and Neurodegeneration in a Mouse Model of Parkinson's DiseaseStefano Espinoza, Margherita Scarpato, Devid Damiani, et al.BMJ Open|February 27, 2026
Efficacy of bumetanide for cognitive improvement in children and adolescents with Down syndrome: study protocol of a randomised, double-blind, placebo-controlled trialFloriana Costanzo, Valentina Maria Mongiovì, Paolo Alfieri, et al.Pageof 5